Nie, J., Yang, L., Huang, L., Gao, L., Young, K. H., Le Grange, J. M., … Zhou, J. (2022). Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS). Cancer Commun (Lond), 42(5), 476–480. https://doi.org/10.1002/cac2.12260

Nie, Jiali, Li Yang, Liang Huang, Lili Gao, Ken He Young, Jehane Michael Le Grange, Xingcheng Yang, Jia Wei, Min Xiao, and Jianfeng Zhou. “Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS).” Cancer Commun (Lond) 42, no. 5 (May 2022): 476–80. https://doi.org/10.1002/cac2.12260.

Nie J, Yang L, Huang L, Gao L, Young KH, Le Grange JM, et al. Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS). Cancer Commun (Lond). 2022 May;42(5):476–80.

Nie, Jiali, et al. “Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS).” Cancer Commun (Lond), vol. 42, no. 5, May 2022, pp. 476–80. Pubmed, doi:10.1002/cac2.12260.

Nie J, Yang L, Huang L, Gao L, Young KH, Le Grange JM, Yang X, Wei J, Xiao M, Zhou J. Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS). Cancer Commun (Lond). 2022 May;42(5):476–480.